MineralRite Corporation filed a Form 8-K on November 2, 2026, disclosing that the Texas Secretary of State filed its Restated Certificate of Formation on October 26, 2026, and that the company's Board of Directors adopted Amended and Restated Bylaws on November 2, 2026, both …
UMH Properties, Inc. filed a Form 8-K with the SEC on November 2, 2026, disclosing its third-quarter results for the period ended September 30, 2026, along with a supplemental information package furnished in connection with its earnings conference call.
Vornado Realty Trust filed a Form 8-K with the SEC on November 2, 2026, announcing the release of its financial results for the third quarter of 2026 via a press release and supplemental operating and financial data.
Neurocrine Biosciences director George Morrow filed a Form 144 notice on November 2, 2026, disclosing a proposed sale of 14,700 shares of common stock acquired through stock option exercises, with an aggregate market value of $2,147,670.00.
Public Service Enterprise Group Incorporated filed its quarterly report on Form 10-Q for the period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 2, 2026, covering both the parent company and its wholly owned utility subsidiary, Public Service Electric …
Cerus Corporation filed a Form S-3 shelf registration statement with the SEC on November 2, 2026, seeking to register up to $150.0 million in securities including common stock, preferred stock, debt securities, and warrants.
A Form 4 filed on November 2, 2026 reports that David Einhorn, a Director and 10% owner of Greenlight Capital Re, Ltd. (NASDAQ:GLRE), disposed of 120,335 ordinary shares on October 30, 2026 through a family trust under a share repurchase agreement with the issuer.
The Goldman Sachs Group, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 2, 2026, reporting third-quarter and nine-month financial results across all business segments.
Commercial Vehicle Group, Inc. filed a Form 8-K on November 2, 2026, disclosing the Board's appointment of David Ruppel as President and Chief Executive Officer effective November 9, 2026, along with third-quarter 2026 earnings results.
Axsome Therapeutics, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 2, 2026, reporting total revenues of $259.7 million for the third quarter.